QUANTITATIVE DIGITAL PATHOLOGY SERVICES
IMAGE ANALYSIS SERVICES BY
RESEARCH PHASE
THERAPEUTIC AREA
TECHNOLOGY
OracleBio is a leading Contract Research Organisation (CRO) specialising in Quantitative Digital Pathology for Pharmaceutical and Biotechnology R&D
Studies Completed
Whole Slide Images (WSI) Analysed
Top Pharmaceutical Companies
By utilising industry-leading Image Analysis platforms – Visiopharm Oncotopix® and Indica Labs HALO® – we deliver expert histopathology image analysis services.
https://oraclebio.com/wp-content/uploads/2019/05/Presentation1-1.jpg 720 1280 Hannah Thomson https://oraclebio.com/wp-content/uploads/2019/09/OracleBio-Logo-Web-3.png Hannah Thomson2019-04-10 15:00:312019-05-16 14:51:28Quantification of Tumour and Stroma Cell Content within Laser Microdissection (LMD) Tissue
https://oraclebio.com/wp-content/uploads/2019/01/TMA-Blog-1-e1548420847561.png 807 807 John Waller https://oraclebio.com/wp-content/uploads/2019/09/OracleBio-Logo-Web-3.png John Waller2019-01-25 12:52:202019-01-29 16:23:46Selecting the Correct Therapeutic Indication: A Case Study Utilising Tissue Microarrays (TMA) with Digital Image Analysis 
https://oraclebio.com/wp-content/uploads/2018/04/histology-quality-blog-thumbnail.jpg 430 430 Hannah Thomson https://oraclebio.com/wp-content/uploads/2019/09/OracleBio-Logo-Web-3.png Hannah Thomson2018-04-25 15:05:362018-04-27 12:43:426 Ways to Improve the Quality of Quantitative Histopathology Data
https://oraclebio.com/wp-content/uploads/2017/08/lag3-image-for-newsletter.jpg 698 698 Hannah Thomson https://oraclebio.com/wp-content/uploads/2019/09/OracleBio-Logo-Web-3.png Hannah Thomson2017-08-08 13:56:322017-08-15 11:17:36Quantification of Dual LAG-3 and CD3 IHC-stained T Cells in Clinical Tumor Tissue using Image Analysis
